Recurrent arteriovenous graft thrombosis in COVID-19 positive patient

Anil Kumar Singh; Saurabh Bansal; Namrata Singhania; Girish Singhania

doi:10.1002/ccr3.4732

Recurrent arteriovenous graft thrombosis in COVID-19 positive patient

Clin Case Rep. 2021 Aug 30;9(9):e04732. doi: 10.1002/ccr3.4732. eCollection 2021 Sep.

Authors

Anil Kumar Singh¹, Saurabh Bansal², Namrata Singhania³, Girish Singhania⁴

Affiliations

¹ Department of Internal Medicine Geisinger Community Medical Center Scranton Pennsylvania USA.
² Department of Internal Medicine University of Illinois College of medicine at Peoria Peoria Illinois USA.
³ Department of Hospital Medicine Mount Carmel East Hospital Columbus Ohio USA.
⁴ Department of Nephrology University of Utah Salt Lake City Utah USA.

Abstract

Hypercoagulability is one of the common complications seen in COVID-19. It can lead to multiple thromboembolic complications. Recurrent arteriovenous graft thrombosis can be one of complications from this pathophysiology.

Keywords: COVID‐19‐associated coagulopathy; arteriovenous graft thrombosis; end‐stage renal disease.

Publication types

Case Reports